期刊
VACCINES
卷 10, 期 10, 页码 -出版社
MDPI
DOI: 10.3390/vaccines10101619
关键词
acetylsalicylic acid; salicylic acid; antiviral activity; aspirin; SARS-CoV-2; precision-cut lung slices
资金
- Bayer Vital GmbH
- Open Access Publication Fund of the University of Wuerzburg
The study found that aspirin and its metabolite salicylic acid can inhibit the replication of SARS-CoV-2 virus in cells. Although these compounds do not interfere with viral entry, they can inhibit post-entry pathways, thereby reducing the expression of viral RNA.
Aspirin, with its active compound acetylsalicylic acid (ASA), shows antiviral activity against rhino- and influenza viruses at high concentrations. We sought to investigate whether ASA and its metabolite salicylic acid (SA) inhibit SARS-CoV-2 since it might use similar pathways to influenza viruses. The compound-treated cells were infected with SARS-CoV-2. Viral replication was analysed by RTqPCR. The compounds suppressed SARS-CoV-2 replication in cell culture cells and a patient-near replication system using human precision-cut lung slices by two orders of magnitude. While the compounds did not interfere with viral entry, it led to lower viral RNA expression after 24 h, indicating that post-entry pathways were inhibited by the compounds.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据